Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Options

<< Previous

Bullboard Posts

Next >>

Comment by lonc17on Nov 26, 2023 10:00pm

137 Views

Post# 35753778

RE:RE:RE:RE:RE:RE:Options

I completely agree with you.

But sadly, given the state of the company at this time and MC and KL's histories, I expect both to dump at least 100,000 shares each (after conversion of options) so as to not be personally out of pocket even one penny.

Look for SEDI to show shares held by them to increase by about 50,000 (not 150,000)

And if this happens everyone should understand it is a signal to sell, pack up and forget about ONC forever.

<< Previous

Bullboard Posts

Next >>

POET increases production capacity to meet AI demand